140 related articles for article (PubMed ID: 16854403)
1. Mutagenicity of stereochemical configurations of 1,2-epoxybutene and 1,2:3,4-diepoxybutane in human lymphblastoid cells.
Meng Q; Redetzke DL; Hackfeld LC; Hodge RP; Walker DM; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):207-18. PubMed ID: 16854403
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE;
Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577
[TBL] [Abstract][Full Text] [Related]
3. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
4. Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts.
Cochrane JE; Skopek TR
Carcinogenesis; 1994 Apr; 15(4):713-7. PubMed ID: 8149485
[TBL] [Abstract][Full Text] [Related]
5. Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane.
Steen AM; Meyer KG; Recio L
Mutagenesis; 1997 Mar; 12(2):61-7. PubMed ID: 9106245
[TBL] [Abstract][Full Text] [Related]
6. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
7. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ
Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or the racemic mixture of 1,2:3,4-diepoxybutane.
Meng Q; Singh N; Heflich RH; Bauer MJ; Walker VE
Mutat Res; 2000 Jan; 464(2):169-84. PubMed ID: 10648904
[TBL] [Abstract][Full Text] [Related]
9. Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice.
Cochrane JE; Skopek TR
Carcinogenesis; 1994 Apr; 15(4):719-23. PubMed ID: 8149486
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity of the racemic mixtures of butadiene monoepoxide and butadiene diepoxide at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats.
Meng Q; Henderson RF; Walker DM; Bauer MJ; Reilly AA; Walker VE
Mutat Res; 1999 Aug; 429(1):127-40. PubMed ID: 10434028
[TBL] [Abstract][Full Text] [Related]
11. Characterization of hprt mutations following 1,2-epoxy-3-butene exposure of human TK6 cells.
Steen AM; Meyer KG; Recio L
Mutagenesis; 1997 Sep; 12(5):359-64. PubMed ID: 9379915
[TBL] [Abstract][Full Text] [Related]
12. Mutations induced by 1,3-butadiene metabolites, butadiene diolepoxide, and 1,2,3,4-diepoxybutane at the Hprt locus in CHO-K1 cells.
Lee DH; Kim TH; Lee SY; Kim HJ; Rhee SK; Yoon B; Pfeifer GP; Lee CS
Mol Cells; 2002 Dec; 14(3):411-9. PubMed ID: 12521305
[TBL] [Abstract][Full Text] [Related]
13. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
14. Comparison of induction of hprt mutations by 1,3-butadiene and/or its metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane in lymphocytes from spleen of adult male mice and rats in vivo.
Tates AD; van Dam FJ; van Teylingen CM; de Zwart FA; Zwinderman AH
Mutat Res; 1998 Jan; 397(1):21-36. PubMed ID: 9463549
[TBL] [Abstract][Full Text] [Related]
15. Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene.
Saranko CJ; Meyer KG; Pluta LJ; Henderson RF; Recio L
Mutat Res; 2001 Jan; 473(1):37-49. PubMed ID: 11166025
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity of 1,3-butadiene and its epoxide metabolites in human TK6 cells and in splenic T cells isolated from exposed B6C3F1 mice.
Cochrane JE; Skopek TR
IARC Sci Publ; 1993; (127):195-204. PubMed ID: 8070866
[TBL] [Abstract][Full Text] [Related]
17. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
Bond JA; Medinsky MA
Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
[TBL] [Abstract][Full Text] [Related]
18. Age-, gender-, and species-dependent mutagenicity in T cells of mice and rats exposed by inhalation to 1,3-butadiene.
Meng Q; Walker DM; McDonald JD; Henderson RF; Carter MM; Cook DL; McCash CL; Torres SM; Bauer MJ; Seilkop SK; Upton PB; Georgieva NI; Boysen G; Swenberg JA; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):121-31. PubMed ID: 16945358
[TBL] [Abstract][Full Text] [Related]
19. The importance of 3,4-epoxy-1,2-butanediol and hydroxymethylvinyl ketone in 3-butene-1,2-diol associated mutagenicity.
Powley MW; Walker VE; Li Y; Upton PB; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):182-90. PubMed ID: 17349618
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and in vitro quantitation of N-7-guanine adducts of diepoxybutane.
Tretyakova NYu ; Sangaiah R; Yen TY; Swenberg JA
Chem Res Toxicol; 1997 Jul; 10(7):779-85. PubMed ID: 9250412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
